Loading
Life sciences · Journal article
Applied Network Science · November 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Pediatric high-grade gliomas (pHGGs) are lethal evolutionary disorders with stalled developmental pathways and disturbed differentiation hierarchies. We integrate transcriptional and algorithmic network complexity-based perturbation analysis to elucidate gene expression patterns and molecular divergence between Diffuse Midline Gliomas (DMG; previously DIPG) and glioblastoma (GBM), revealing shared developmental programs steering cell fate decision-making. Our complex systems approach supports the emerging paradigm that pHGGs are neurodevelopmental disorders with hybrid lineage identities and disrupted patterning. We identify dysregulated neurodevelopmental and morphogenetic signatures, alongside bioelectric and neurotransmitter signaling programs that alter synaptic organization, neuronal fate commitment, and phenotypic plasticity, regulating glioma phenotypic switching (cell state-transitions). In silico candidate transition-associated network signatures and regulators of plasticity were predicted as possible predictive biomarkers and therapeutic targets, reinforcing the view that pediatric gliomas are disorders of cell fate decisions and collective cellular identity. Neuronal and synaptic enrichment is interpreted as a candidate neurodevelopmental network program emerging from disrupted cell fate decision-making. Across validation cohorts, these predictive signatures localized to progenitor-like, NPC/OPC-like, hybrid/ambiguous, immune, and extracellular matrix-associated compartments, supporting recurrence-associated plasticity dynamics. Decoded cell fate transition-associated signatures indicate recurrence-associated remodeling of neural progenitor, OPC-like, neurosynaptic interface, immune, and matrisome-associated programs, as computationally inferred network features. Using graph network-based complexity signatures, our algorithms identified candidate network-associated plasticity markers and interpretable regulatory drivers underlying latent glioma cell fate dynamics. These computational findings may help advance ‘differentiation therapy’ as a systems medicine strategy, discovering plasticity regulators to reprogram malignant fates toward stable lineages, offering complex systems-based targets for cancer reversion and predictive, preventive, and precision oncology.